Twin Health completed $53 million Series E Round funding at $950 million valuation
Sector:
Healthcare
08/22/2025
Mountain View, CA USA
Twin Health
completed $53 million Series E Round funding at $950 million valuation. Investors include
Maj Invest (lead), Temasek, ICONIQ Growth.
“Diabetes doesn’t occur by itself,” said Jahangir Mohammed, founder and CEO of Twin Health. “It occurs as a cluster of diseases—it’s diabetes, hypertension, bad cholesterol, fatty liver, chronic kidney disease. These things happen together, and when not addressed, they show up as heart failure, kidney failure and Alzheimer’s… These are the most prevalent diseases, globally affecting over two billion people. In the U.S., we spend one trillion dollars and still see 1.5 million premature deaths. It turns out there’s one root cause—dysfunctional metabolism. Can you imagine, the world’s largest problem has one root cause and we haven’t solved it?”
About
Twin Health combines advanced medical science and technology with a clinical care team to help people take control of conditions like type 2 diabetes, prediabetes, and obesity. Twin is a metabolic health benefit offered exclusively through employers or health plans.
Our Digital Twin™ technology learns a member’s unique metabolism based on insights collected from smart devices, meal logs, and lab work. By seeing how their body responds to lifestyle choices, Twin can provide real-time, personalized recommendations on nutrition, activity, sleep, stress, and more. Our clinical care team then guides the member on a clear path toward their health goals, celebrating each win along the way.
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
